Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ZM-H1505R plus entecavir versus entecavir alone in chronic hepatitis B patients; efficacy and safety results not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• ZM-H1505R

Snippet

Sponsor: Shanghai Zhimeng Biopharma, Inc. | Conditions: Hepatitis B, Chronic | Phase 2 | Status: UNKNOWN